Literature DB >> 6924646

An evaluation of daily bacteriologic monitoring to identify preventable episodes of catheter-associated urinary tract infection.

R A Garibaldi, B R Mooney, B J Epstein, M R Britt.   

Abstract

We evaluated the efficacy of a daily bacteriologic monitoring program for preventing symptomatic urinary tract infections (UTI) in hospitalized patients with temporary indwelling urethral catheters. We identified 99 instances in which bacteriuria was present at the time of catheter insertion among 1,140 catheterizations. Of those, 62 patients were asymptomatic and 37 patients had fever or symptoms attributable to UTI. Of the 37 symptomatic episodes, only 14 developed symptoms 24 hours or more after the first culture and might be considered potentially preventable. We also identified 76 episodes of acquired bacteriuria among 608 catheterizations that were initially nonbacteriuric in which at least two cultures were available. Of these 76 patients, 51 (67%) remained asymptomatic throughout their period of hospitalization. Of the 25 patients who developed symptomatic infections, only ten were potentially preventable. In all, only 24 symptomatic episodes among 1,140 catheterizations (2%) occurred 24 hours or more after colonization was first detected and might be considered potentially preventable. Our data suggest that routine daily bacteriologic monitoring of urine from all catheterized patients is not an efficient way to decrease the incidence of symptomatic, catheter-associated UTI.

Entities:  

Mesh:

Year:  1982        PMID: 6924646     DOI: 10.1017/s0195941700056599

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  17 in total

Review 1.  Treatment of urinary tract infection. Clinical and economic considerations.

Authors:  R J Plumridge; C L Golledge
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

2.  Prevention and treatment of urinary catheter-associated infections.

Authors:  Mayar Al Mohajer; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

3.  epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  R J Pratt; C M Pellowe; J A Wilson; H P Loveday; P J Harper; S R L J Jones; C McDougall; M H Wilcox
Journal:  J Hosp Infect       Date:  2007-02       Impact factor: 3.926

4.  Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model.

Authors:  Susan M Lehman; Rodney M Donlan
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

Review 5.  Nosocomial infections in neurocritical care.

Authors:  Rafael Ortiz; Kiwon Lee
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

6.  An evaluation of the management of asymptomatic catheter-associated bacteriuria and candiduria at The Ottawa Hospital.

Authors:  Dawn M Dalen; Rosemary K Zvonar; Peter G Jessamine
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-05       Impact factor: 2.471

7.  Urinary tract infections in the city of Florence: epidemiological considerations over a twenty-year period.

Authors:  G Corti; E Giganti; F Paradisi; P Nicoletti
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

Review 8.  Engineering out the risk for infection with urinary catheters.

Authors:  D G Maki; P A Tambyah
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

Review 9.  Prevention and treatment of urinary catheter-related infections in older patients.

Authors:  L E Nicolle
Journal:  Drugs Aging       Date:  1994-05       Impact factor: 3.923

10.  Effect of nonpayment for hospital-acquired, catheter-associated urinary tract infection: a statewide analysis.

Authors:  Jennifer A Meddings; Heidi Reichert; Mary A M Rogers; Sanjay Saint; Joe Stephansky; Laurence F McMahon
Journal:  Ann Intern Med       Date:  2012-09-04       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.